Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Dye & Durham Seals Agreements With Plantro And Edgepoint

Dye & Durham Seals Agreements With Plantro And Edgepoint

MT newswireMT newswire2026/11/05 16:50
12:50 PM EST, 11/05/2026 (MT Newswires) -- Dye & Durham (DND.TO) on Thursday said it struck support agreements with Plantro and EdgePoint, who jointly have a 36% equity stake in the company. The litigation between Dye & Durham and Plantro will be dismissed. Former Dye & Durham Global Chief Executive Officer Matthew Proud, Lee Matheson of Edgepoint, and former Dye & Durham director Peter Brimm have also been appointed to the board, a statement said. Dye & Durham shares were last seen down CA$0.04 at CA$1.51 on the Toronto Stock Exchange. Price: 1.52, Change: -0.03, Percent Change: -1.94
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss